Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Szöllősi J[au]:

Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer. Costea T et al. Int J Mol Sci. (2019)

Flow Cytometric FRET Analysis of Protein Interactions. Ujlaky-Nagy L et al. Methods Mol Biol. (2018)

Understanding FRET as a research tool for cellular studies. Shrestha D et al. Int J Mol Sci. (2015)

Search results

Items: 1 to 50 of 226

1.

EGF Receptor Stalls upon Activation as Evidenced by Complementary Fluorescence Correlation Spectroscopy and Fluorescence Recovery after Photobleaching Measurements.

Vámosi G, Friedländer-Brock E, Ibrahim SM, Brock R, Szöllősi J, Vereb G.

Int J Mol Sci. 2019 Jul 9;20(13). pii: E3370. doi: 10.3390/ijms20133370.

2.

Reducing the Detrimental Effects of Saturation Phenomena in FRET Microscopy.

Szendi-Szatmári T, Szabó Á, Szöllősi J, Nagy P.

Anal Chem. 2019 May 7;91(9):6378-6382. doi: 10.1021/acs.analchem.9b01504. Epub 2019 Apr 24.

PMID:
30993981
3.

Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.

Costea T, Nagy P, Ganea C, Szöllősi J, Mocanu MM.

Int J Mol Sci. 2019 Mar 1;20(5). pii: E1062. doi: 10.3390/ijms20051062. Review.

4.

Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation.

Barok M, Puhka M, Vereb G, Szollosi J, Isola J, Joensuu H.

BMC Cancer. 2018 May 2;18(1):504. doi: 10.1186/s12885-018-4418-2.

5.

Smoking cessation support for regular smokers in Hungarian primary care: a nationwide representative cross-sectional study.

Sipos V, Pálinkás A, Kovács N, Csenteri KO, Vincze F, Szőllősi JG, Jenei T, Papp M, Ádány R, Sándor J.

BMJ Open. 2018 Feb 3;8(2):e018932. doi: 10.1136/bmjopen-2017-018932.

6.

The Effect of Fluorophore Conjugation on Antibody Affinity and the Photophysical Properties of Dyes.

Szabó Á, Szendi-Szatmári T, Ujlaky-Nagy L, Rádi I, Vereb G, Szöllősi J, Nagy P.

Biophys J. 2018 Feb 6;114(3):688-700. doi: 10.1016/j.bpj.2017.12.011.

7.

Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease.

Batta G, Soltész L, Kovács T, Bozó T, Mészár Z, Kellermayer M, Szöllősi J, Nagy P.

Sci Rep. 2018 Jan 9;8(1):157. doi: 10.1038/s41598-017-18405-8.

8.

Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines.

Filippi A, Picot T, Aanei CM, Nagy P, Szöllősi J, Campos L, Ganea C, Mocanu MM.

Int J Food Sci Nutr. 2018 Aug;69(5):584-597. doi: 10.1080/09637486.2017.1401980. Epub 2017 Nov 21.

PMID:
29157036
9.

Flow Cytometric FRET Analysis of Protein Interactions.

Ujlaky-Nagy L, Nagy P, Szöllősi J, Vereb G.

Methods Mol Biol. 2018;1678:393-419. doi: 10.1007/978-1-4939-7346-0_17.

PMID:
29071688
10.
11.

Detection of protein interactions by Subcellular Localization Assay.

Mocanu MM, Nagy P, Szöllősi J.

Cytometry A. 2017 Jul;91(7):657-658. doi: 10.1002/cyto.a.23153. Epub 2017 Jul 12. No abstract available.

12.

The dipole potential correlates with lipid raft markers in the plasma membrane of living cells.

Kovács T, Batta G, Zákány F, Szöllősi J, Nagy P.

J Lipid Res. 2017 Aug;58(8):1681-1691. doi: 10.1194/jlr.M077339. Epub 2017 Jun 12.

13.

The Dipole Potential Modifies the Clustering and Ligand Binding Affinity of ErbB Proteins and Their Signaling Efficiency.

Kovács T, Batta G, Hajdu T, Szabó Á, Váradi T, Zákány F, Csomós I, Szöllősi J, Nagy P.

Sci Rep. 2016 Oct 24;6:35850. doi: 10.1038/srep35850.

14.

The flow of events: How the sequence of molecular interactions is seen by the latest, user-friendly high throughput flow cytometric FRET.

Szöllősi J, Vereb G, Nagy P.

Cytometry A. 2016 Oct;89(10):881-885. doi: 10.1002/cyto.a.22994. Epub 2016 Oct 13. No abstract available.

15.

MHC I Expression Regulates Co-clustering and Mobility of Interleukin-2 and -15 Receptors in T Cells.

Mocsár G, Volkó J, Rönnlund D, Widengren J, Nagy P, Szöllősi J, Tóth K, Goldman CK, Damjanovich S, Waldmann TA, Bodnár A, Vámosi G.

Biophys J. 2016 Jul 12;111(1):100-12. doi: 10.1016/j.bpj.2016.05.044.

17.

Association between periodontal status and idiopathic male infertility.

Pásztor N, Kárpáti K, Szöllősi J, Keresztúri M, Kozinszky Z, Gorzó I, Radnai M.

J Oral Sci. 2016;58(2):247-53. doi: 10.2334/josnusd.15-0586.

18.

rFRET: A comprehensive, Matlab-based program for analyzing intensity-based ratiometric microscopic FRET experiments.

Nagy P, Szabó Á, Váradi T, Kovács T, Batta G, Szöllősi J.

Cytometry A. 2016 Apr;89(4):376-84. doi: 10.1002/cyto.a.22828. Epub 2016 Mar 22.

19.

Chemoprevention of Breast Cancer by Dietary Polyphenols.

Mocanu MM, Nagy P, Szöllősi J.

Molecules. 2015 Dec 17;20(12):22578-620. doi: 10.3390/molecules201219864. Review.

20.

Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms.

Szöőr Á, Ujlaky-Nagy L, Tóth G, Szöllősi J, Vereb G.

Cell Signal. 2016 Feb;28(2):81-93. doi: 10.1016/j.cellsig.2015.11.012. Epub 2015 Dec 2.

PMID:
26631574
21.

Pregnancy Rate after Controlled Ovarian Hyperstimulation and Intrauterine Insemination for the Treatment of Endometriosis following Surgery.

Keresztúri A, Kozinszky Z, Daru J, Pásztor N, Sikovanyecz J, Zádori J, Márton V, Koloszár S, Szöllősi J, Németh G.

Biomed Res Int. 2015;2015:282301. doi: 10.1155/2015/282301. Epub 2015 Jul 12.

22.

Understanding FRET as a research tool for cellular studies.

Shrestha D, Jenei A, Nagy P, Vereb G, Szöllősi J.

Int J Mol Sci. 2015 Mar 25;16(4):6718-56. doi: 10.3390/ijms16046718. Review.

23.

À la Fizeau in flow: pulse shape-assisted fluorescence lifetime.

Bene L, Szöllősi J.

Cytometry A. 2014 Dec;85(12):991-4. doi: 10.1002/cyto.a.22583. Epub 2014 Nov 5. Review. No abstract available.

24.

TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.

Govers C, Sebestyén Z, Roszik J, van Brakel M, Berrevoets C, Szöőr Á, Panoutsopoulou K, Broertjes M, Van T, Vereb G, Szöllősi J, Debets R.

J Immunol. 2014 Nov 15;193(10):5315-26. doi: 10.4049/jimmunol.1302074. Epub 2014 Oct 15.

25.

FRET Imaging by Laser Scanning Cytometry on Large Populations of Adherent Cells.

Doan-Xuan QM, Szalóki N, Tóth K, Szöllősi J, Bacso Z, Vámosi G.

Curr Protoc Cytom. 2014 Oct 1;70:2.23.1-29. doi: 10.1002/0471142956.cy0223s70. Review.

PMID:
25271960
26.

Maximum likelihood estimation of FRET efficiency and its implications for distortions in pixelwise calculation of FRET in microscopy.

Nagy P, Szabó A, Váradi T, Kovács T, Batta G, Szöllősi J.

Cytometry A. 2014 Nov;85(11):942-52. doi: 10.1002/cyto.a.22518. Epub 2014 Aug 13.

27.

CD1d favors MHC neighborhood, GM1 ganglioside proximity and low detergent sensitive membrane regions on the surface of B lymphocytes.

Shrestha D, Exley MA, Vereb G, Szöllősi J, Jenei A.

Biochim Biophys Acta. 2014 Jan;1840(1):667-80.

PMID:
24482817
28.

Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.

Mocanu MM, Ganea C, Georgescu L, Váradi T, Shrestha D, Baran I, Katona E, Nagy P, Szöllősi J.

J Nat Prod. 2014 Feb 28;77(2):250-7. doi: 10.1021/np4007712. Epub 2014 Jan 23.

PMID:
24456004
29.

Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid rafts.

Király A, Váradi T, Hajdu T, Rühl R, Galmarini CM, Szöllősi J, Nagy P.

Mar Drugs. 2013 Dec 2;11(12):4858-75. doi: 10.3390/md11124858.

30.

High throughput FRET analysis of protein-protein interactions by slide-based imaging laser scanning cytometry.

Szalóki N, Doan-Xuan QM, Szöllősi J, Tóth K, Vámosi G, Bacsó Z.

Cytometry A. 2013 Sep;83(9):818-29. doi: 10.1002/cyto.a.22315. Epub 2013 Jul 10.

31.

Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.

Petrás M, Lajtos T, Friedländer E, Klekner A, Pintye E, Feuerstein BG, Szöllosi J, Vereb G.

Neuro Oncol. 2013 Aug;15(8):1027-40. doi: 10.1093/neuonc/not046. Epub 2013 Apr 17.

32.

TripleFRET measurements in flow cytometry.

Fábián Á, Horváth G, Vámosi G, Vereb G, Szöllősi J.

Cytometry A. 2013 Apr;83(4):375-85. doi: 10.1002/cyto.a.22267. Epub 2013 Mar 15.

33.

Validating pharmacological disruption of protein-protein interactions by acceptor photobleaching FRET imaging.

Roszik J, Tóth G, Szöllősi J, Vereb G.

Methods Mol Biol. 2013;986:165-78. doi: 10.1007/978-1-62703-311-4_11.

PMID:
23436412
34.

Clinical cytometry in Europe, 2012.

Kappelmayer J, Rawstron A, Szöllosi J, Gratama JW.

Cytometry B Clin Cytom. 2012 Nov;82(6):372-3. doi: 10.1002/cyto.b.21049. No abstract available.

35.

The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.

Fábián Á, Vereb G, Szöllősi J.

Cytometry A. 2013 Jan;83(1):62-71. doi: 10.1002/cyto.a.22206. Epub 2012 Sep 20. Review.

36.

Comparative study of the three different fluorophore antibody conjugation strategies.

Shrestha D, Bagosi A, Szöllősi J, Jenei A.

Anal Bioanal Chem. 2012 Sep;404(5):1449-63. doi: 10.1007/s00216-012-6232-z. Epub 2012 Jul 14.

PMID:
22797718
37.

Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.

Váradi T, Mersich T, Auvinen P, Tammi R, Tammi M, Salamon F, Besznyák I Jr, Jakab F, Baranyai Z, Szöllősi J, Nagy P.

J Histochem Cytochem. 2012 Aug;60(8):567-75. doi: 10.1369/0022155412448070. Epub 2012 May 4.

38.

How to avoid bleeding in Förster resonance energy transfer.

Nagy P, Szöllosi J.

Cytometry A. 2012 Feb;81(2):108-9. doi: 10.1002/cyto.a.21165. Epub 2011 Nov 10. No abstract available.

39.

Bare lymphocyte syndrome: an opportunity to discover our immune system.

Shrestha D, Szöllosi J, Jenei A.

Immunol Lett. 2012 Jan 30;141(2):147-57. doi: 10.1016/j.imlet.2011.10.007. Epub 2011 Oct 17. Review.

PMID:
22027563
40.

ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment.

Váradi T, Roszik J, Lisboa D, Vereb G, Molina-Guijarro JM, Galmarini CM, Szöllosi J, Nagy P.

Eur J Pharmacol. 2011 Sep 30;667(1-3):91-9. doi: 10.1016/j.ejphar.2011.05.064. Epub 2011 Jun 2.

PMID:
21658382
41.

Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA).

Mocanu MM, Váradi T, Szöllosi J, Nagy P.

Proteomics. 2011 May;11(10):2063-70. doi: 10.1002/pmic.201100028. Epub 2011 Apr 8.

PMID:
21480528
42.

T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapy.

Roszik J, Sebestyén Z, Govers C, Guri Y, Szöor A, Pályi-Krekk Z, Vereb G, Nagy P, Szöllosi J, Debets R.

Eur J Immunol. 2011 May;41(5):1288-97. doi: 10.1002/eji.200940233. Epub 2011 Apr 13.

43.

Steps in metastasis research: analyzing, collecting, and culturing circulating tumor cells.

Barok M, Szollosi J.

Cytometry A. 2011 Feb;79(2):93-4. doi: 10.1002/cyto.a.21025. No abstract available.

44.

Flow cytometric FRET analysis of protein interaction.

Vereb G, Nagy P, Szöllosi J.

Methods Mol Biol. 2011;699:371-92. doi: 10.1007/978-1-61737-950-5_18.

PMID:
21116993
45.

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.

Vondálová Blanárová O, Jelínková I, Szöor A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P, Szöllosi J, Hofmanová J, Vereb G, Kozubík A.

Carcinogenesis. 2011 Jan;32(1):42-51. doi: 10.1093/carcin/bgq220. Epub 2010 Oct 29.

PMID:
21037225
46.

Strength in numbers: effects of acceptor abundance on FRET efficiency.

Fábián ÁI, Rente T, Szöllosi J, Mátyus L, Jenei A.

Chemphyschem. 2010 Dec 3;11(17):3713-21. doi: 10.1002/cphc.201000568.

PMID:
20936620
47.

The role of hyaluronic acid binding assay in choosing the fertilization method for patients undergoing IVF for unexplained infertility.

Kovacs P, Kovats T, Sajgo A, Szollosi J, Matyas S, Kaali SG.

J Assist Reprod Genet. 2011 Jan;28(1):49-54. doi: 10.1007/s10815-010-9479-3. Epub 2010 Sep 15.

48.

Coclustering of ErbB1 and ErbB2 revealed by FRET-sensitized acceptor bleaching.

Szabó A, Szöllosi J, Nagy P.

Biophys J. 2010 Jul 7;99(1):105-14. doi: 10.1016/j.bpj.2010.03.061.

49.

CYTO 2010--overview of the XXV ISAC Congress Proceedings Issue of Cytometry Part A.

Szöllosi J, Smith PJ.

Cytometry A. 2010 May;77(5):407-9. doi: 10.1002/cyto.a.20894. No abstract available.

50.

Characterization of a novel, trastuzumab resistant human breast cancer cell line.

Barok M, Balazs M, Lazar V, Rakosy Z, Toth E, Treszl A, Vereb G, Colbern GT, Park JW, Szollosi J.

Front Biosci (Elite Ed). 2010 Jan 1;2:627-40.

PMID:
20036907

Supplemental Content

Loading ...
Support Center